To study, for the first time, service utilization and costs in fibromyalgia, a prevalent syndrome associated with high levels of pain, functional disability, and emotional distress.
Five hundred thirty-eight fibromyalgia patients from 6 rheumatology centers were enrolled in a 7-year prospective study of fibromyalgia outcome.
Patients were assessed every 6 months with validated, mailed questionnaires which included questions regarding fibromyalgia symptoms and severity, utilization of services, and work disability.
Fibromyalgia patients averaged almost 10 outpatient medical visits per year, and when nontraditional treatments were considered, this number increased to ~1 visit per month.
Patients were hospitalized at a rate of 1 hospitalization every 3 years.
In each 6-month study period, patients used a mean of 2.7 fibromyalgia-related drugs.
Costs increased over the course of the study.
The mean yearly per-patient cost in 1996 dollars was $2,274.
However, results were skewed by high utilizers, and many patients used few services and had limited costs.
Total costs and utilization were independently associated with the number of self-reported comorbid or associated conditions, functional disability, and global disease severity. (...)
Mots-clés Pascal : Fibromyalgie, Homme, Traitement, Epidémiologie, Incidence, Analyse coût efficacité, Service santé, Pronostic, Long terme, Douleur, Système ostéoarticulaire pathologie, Muscle strié pathologie
Mots-clés Pascal anglais : Fibromyalgia, Human, Treatment, Epidemiology, Incidence, Cost efficiency analysis, Health service, Prognosis, Long term, Pain, Diseases of the osteoarticular system, Striated muscle disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0512491
Code Inist : 002B15I. Création : 13/02/1998.